NPY promoted an antinociceptive effect that was inhibited with Y1R or Y2R antagonists (BIBO3304 and BIIEo246, respectively), and the peptide was upregulated in cancer-induced bone pain [81]. The gene discussed is NPY; the disease is cancer.